Expediting Comprehensive Molecular Analysis to Optimize Initial Treatment of Lung Cancer Patients With Minimal Smoking History-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Expediting Comprehensive Molecular Analysis to Optimize Initial Treatment of Lung Cancer Patients With Minimal Smoking History

Published:2019-05 Issue:5 Volume:14 Page:835-843
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Dagogo-Jack Ibiayi^ORCID,Robinson Hayley,Mino-Kenudson Mari,Farago Anna F.,Kamesan Vashine,Iafrate A. John,Shaw Alice T.,Lennerz Jochen K.

Funder

Boehringer Ingelheim

Pharmaceuticals

Bayer

Genentech

Roche

AbbVie

Chugai

Pfizer

Novartis

Ariad

TP Therapeutics

Takeda

EMD Serono during the conduct of the study

Blueprint

Daiichi-Sankyo

Taiho

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference20 articles.

1. Prospective comprehensive molecular characterization of lung adenocarcinomas for efficient patient matching to approved and emerging therapies;Jordan;Cancer Discov,2017

2. Pembrolizumab versus chemotherapy for PD-L1–positive non–small-cell lung cancer;Reck;N Engl J Med,2016

3. Alectinib versus crizotinib in untreated ALK-positive non–small-cell lung cancer;Peters;N Engl J Med,2017

4. Osimertinib in untreated EGFR-mutated advanced non–small-cell lung cancer;Soria;N Engl J Med,2018

5. Pembrolizumab plus chemotherapy in metastatic non–small-cell lung cancer;Gandhi;N Engl J Med,2018

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Administrative Alignment for Integrated Diagnostics Leads to Shortened Time to Diagnose and Service Optimization;Radiology;2024-07-01

2. Biomarker Turnaround Times and Impact on Treatment Decisions in Patients with Advanced Non-Small Cell Lung Carcinoma at a Large Canadian Community Hospital with an Affiliated Regional Cancer Centre;Current Oncology;2024-03-14

3. Integrated Radiology, Pathology, and Pharmacy Program to Accelerate Access to Osimertinib;JCO Oncology Practice;2023-09

4. Ultrafast Gene Fusion Assessment for Nonsquamous NSCLC;JTO Clinical and Research Reports;2023-02

5. Economic Analysis of Exclusionary EGFR Test Versus Up-Front NGS for Lung Adenocarcinoma in High EGFR Mutation Prevalence Areas;Journal of the National Comprehensive Cancer Network;2022-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3